Home » Newsletters » BioWorld Science

BioWorld Science

May 15, 2009

View Archived Issues

Novel calpain inhibitor Neurodur preserves postischemia retinal function in rodents

Clomiphene citrate compared to testosterone gel in retrospective hypogonadism study

Pfizer updates Q1 progress

Roche develops RO-4929097 to target Notch for tumor growth inhibition

Aminoflavone prodrug AFP-464 tested in advanced cancer patients: phase I PK/PD data presented

Data presented on novel Hsp90 inhibitors from Novartis/Vernalis collaboration

Virally derived channelrhodopsin restores visual function in adult rd1 mice

Circassia initiates phase II clinical trial with ToleroMune ragweed allergy therapy

FDA approves Takeda's ACTOplus met XR for type 2 diabetes

SuppreMol initiates dosing in phase I clinical trial of autoimmune drug SM-101

Preclinical activity of novel oncolytic agent SR-13676 described

Calcitonin gene-related peptide antagonists claimed by Boehringer Ingelheim as analgesics

AstraZeneca patents novel metabotropic glutamate mGluR5 receptor antagonists

Takeda describes novel renin inhibitors as antihypertensive agents

Multi-antigen adenovector malaria vaccine shows no protection from parasitemia in phase I/IIa trial

Novel recombinant vaccine for tuberculosis deemed safe in healthy Gambian infants

BTZ-043, a novel inhibitor of arabinan cell wall synthesis, developed as candidate for tuberculosis

Apogenix presents positive phase I APG-101 results

Banyan Biomarkers targets protein biomarkers for brain injury detection

EMEA grants approval to proceed with phase III Onalta development

FDA accepts Aridol mannitol bronchial challenge test NDA for review

Ferring reveals efficacy data for Eufelexxa in osteoarthritis knee pain

Primary endpoint achieved in phase II MDX-1100 trial for rheumatoid arthritis

Revascor shown to improve heart muscle function in phase II study

Stem Cell Therapeutics to initiate phase IIb trial of NTx-265 in acute ischemic stroke

China Aoxing acquires rights to TJSL for primary dysmenorrhea in adult women

Aegera initiates phase IIa clinical trial of AEG-33773 in diabetic peripheral neuropathy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...